There are only few data concerning persistence of neutralizing antibodies (NAbs) among
SARS-CoV-2-infected healthcare workers (HCW). These individuals are particularly …

Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS …

Objectives To evaluate longitudinally the persistence of humoral immunity for up to 6 months
in a cohort of hospital employees with mild coronavirus disease 2019 (COVID-19). Methods …

In order to support vaccine development, and to aid convalescent plasma therapy, it would
be important to understand the kinetics, timing and persistence of SARS-CoV-2 neutralizing …

Understanding antibody responses to SARS-CoV-2 is indispensable for the development of
containment measures to overcome the current COVID-19 pandemic. Recent studies …

Background During the coronavirus disease 2019 (COVID-19) pandemic, many countries
experienced infection in health care workers (HCW) due to overburdened health care …

Background The COVID-19 pandemic caused by SARS-CoV-2 coronavirus threatens global
public health. Currently, neutralizing antibodies (NAbs) versus this virus are expected to …

Although antibody response to SARS-CoV-2 can be detected early during the infection,
several outstanding questions remain to be addressed regarding the magnitude and …

Abstract Background Coronavirus disease 2019 (COVID-19) is a global pandemic with no
licensed vaccine or specific antiviral agents for therapy. Little is known about the longitudinal …

Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal
characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 …